Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 2 March 2021
First Online: 9 April 2021
Competing interests
: M.H.S. is a co-founder and board member of Teiko Bio, receives research funding from Roche/Genentech, Bristol-Myers Squibb and Valitor, and has been a paid consultant for Earli, Five Prime Therapeutics, Ono Pharmaceutical and January Inc. B.M.A. is currently an employee of Teiko Bio. K.J.H.-G. declares no competing interests.
